[JSNP Excellent Presentation Award for AsCNP 2011: involvement of 5-HT(1A) receptors in fluvoxamine-induced enhancement of prefrontal dopamine release].
N
N
Hiramatsu
Y
Y
Ago
K
K
Yano
K
K
Takuma
M
M
Matsuda
D000315:Adrenalectomy / Q000009:adverse effects; D000818:Animals; D001363:Awards and Prizes; D002369:Castration / Q000009:adverse effects; D004298:Dopamine / Q000378:metabolism*; D016666:Fluvoxamine / Q000494:pharmacology*; D008297:Male; D051379:Mice; D017551:Microdialysis / Q000379:methods; D009638:Norepinephrine / Q000378:metabolism; D017397:Prefrontal Cortex / Q000187:drug effects* / Q000378:metabolism; D044282:Receptor, Serotonin, 5-HT1A / Q000378:metabolism*; D012701:Serotonin / Q000378:metabolism; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology*
D004298:Dopamine; D016666:Fluvoxamine; D009638:Norepinephrine; D044282:Receptor, Serotonin, 5-HT1A; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors